Literature DB >> 9683294

Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer.

A Lösch1, C Tempfer, P Kohlberger, E A Joura, M Denk, B Zajic, G Breitenecker, C Kainz.   

Abstract

This study investigated the prognostic value of immunohistochemically detected cathepsin D expression in 103 invasive ductal carcinomas of the breast at stages pT1 and 2. We also assessed the association between cathepsin D expression and histomorphological tumour subtypes (invasive ductal carcinoma with extensive intraductal component, multifocal tumour). Cathepsin D expression was examined at two cut-off levels (positive and highly positive) and separately identified within the epithelial and stromal component of all tumours. Positive and highly positive epithelial expression was detected in 32 (31.1%) and 20 (19.4%) patients respectively. Stromal expression was found in 35 (34%) and 19 (18.4%) cases respectively. Epithelial cathepsin D expression was associated with stage and nuclear grade, but not with lymph node or oestrogen receptor status. Positive and highly positive epithelial cathepsin D expression showed significant prognostic value for overall survival (P = 0.003 and 0.01) and recurrence-free interval (P = 0.04 and 0.02). Cathepsin D expression in stromal cells was not associated with either several established prognostic factors or survival. Multivariate analysis revealed that cathepsin D expression failed to be an independent predictor of patients' outcome. Cathepsin D expression shows no significant association with histomorphological subtypes of breast cancer. Our study supports the prognostic impact of immunohistochemically detected cathepsin D expression in the epithelial component of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683294      PMCID: PMC2062888          DOI: 10.1038/bjc.1998.465

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

2.  Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast.

Authors:  S G Silverberg; A R Chitale
Journal:  Cancer       Date:  1973-10       Impact factor: 6.860

Review 3.  Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis?

Authors:  H Rochefort; F Capony; M Garcia; V Cavaillès; G Freiss; M Chambon; M Morisset; F Vignon
Journal:  J Cell Biochem       Date:  1987-09       Impact factor: 4.429

4.  Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.

Authors:  U J Göhring; A Scharl; U Thelen; A Ahr; G Crombach; B R Titius
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

5.  Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.

Authors:  J A Henry; A L McCarthy; B Angus; B R Westley; F E May; S Nicholson; J Cairns; A L Harris; C H Horne
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

6.  Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.

Authors:  W Domagala; G Striker; A Szadowska; A Dukowicz; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

7.  Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.

Authors:  J Isola; S Weitz; T Visakorpi; K Holli; R Shea; N Khabbaz; O P Kallioniemi
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

8.  Cathepsin D and prognosis in breast cancer.

Authors:  A K Tandon; G M Clark; G C Chamness; J M Chirgwin; W L McGuire
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

9.  Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer.

Authors:  P L Kandalaft; K L Chang; C W Ahn; S T Traweek; P Mehta; H Battifora
Journal:  Cancer       Date:  1993-05-01       Impact factor: 6.860

10.  Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

Authors:  S M Thorpe; H Rochefort; M Garcia; G Freiss; I J Christensen; S Khalaf; F Paolucci; B Pau; B B Rasmussen; C Rose
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

View more
  4 in total

1.  Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.

Authors:  M Ikeguchi; T Sakatani; T Ueta; K Fukuda; S Oka; K Hisamitsu; K Yamaguchi; S Tsujitani; N Kaibara
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.

Authors:  A Scorilas; T Trangas; J Yotis; C Pateras; M Talieri
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

3.  Cathepsins B, D, and G Are Expressed in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma.

Authors:  Felix Humphries; Bridget Chang-McDonald; Josie Patel; Nicholas Bockett; Erin Paterson; Paul F Davis; Swee T Tan
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

4.  To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach.

Authors:  I-Shiang Tzeng
Journal:  J Clin Lab Anal       Date:  2021-05-27       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.